Abstract:BACKGROUND: The intestinal mucosal barrier is the first line of defense against numerous harmful substances, and it contributes to the maintenance of intestinal homeostasis. Recent studies reported that structural and functional changes in the intestinal mucosal barrier were involved in the pathogenesis of several intestinal diseases. However, no study thoroughly evaluated this barrier in patients with functional constipation (FC).AIM: To investigate the intestinal mucosal barrier in FC, including the mucus barrier, intercellular junctions, mucosal immunity and gut permeability.METHODS: Forty FC patients who fulfilled the Rome IV criteria and 24 healthy controls were recruited in the Department of Gastroenterology of China-Japan Friendship Hospital. The colonic mucus barrier, intercellular junctions in the colonic epithelium, mucosal immune state and gut permeability in FC patients were comprehensively examined. Goblet cells were stained with Alcian Blue/Periodic acid Schiff (AB/PAS) and counted. The ultrastructure of intercellular junctional complexes was observed under an electron microscope. Occludin and zonula occludens-1 (ZO-1) in the colonic mucosa were located and quantified using immunohistochemistry and quantitative real-time polymerase chain reaction. Colonic CD3+ intraepithelial lymphocytes (IELs) and CD3+ lymphocytes in the lamina propria were identified and counted using immunofluorescence. The serum levels of D-lactic acid and zonulin were detected using enzyme-linked immunosorbent assay.RESULTS: Compared to healthy controls, the staining of mucus secreted by goblet cells was darker in FC patients, and the number of goblet cells per upper crypt in the colonic mucosa was significantly increased in FC patients (control, 18.67 ± 2.99; FC, 22.42 ± 4.09; P = 0.001). The intercellular junctional complexes in the colonic epithelium were integral in FC patients. The distribution of mucosal occludin and ZO-1 was not altered in FC patients. No significant differences were found in occludin (control, 5.76E-2 ± 1.62E-2; FC, 5.17E-2 ± 1.80E-2; P = 0.240) and ZO-1 (control, 2.29E-2 ± 0.93E-2; FC, 2.68E-2 ± 1.60E-2; P = 0.333) protein expression between the two groups. The mRNA levels in occludin and ZO-1 were not modified in FC patients compared to healthy controls (P = 0.145, P = 0.451, respectively). No significant differences were observed in the number of CD3+ IELs per 100 epithelial cells (control, 5.62 ± 2.06; FC, 4.50 ± 2.16; P = 0.070) and CD3+ lamina propria lymphocytes (control, 19.69 ± 6.04/mm2; FC, 22.70 ± 11.38/mm2; P = 0.273). There were no significant differences in serum D-lactic acid [control, 5.21 (4.46, 5.49) mmol/L; FC, 4.63 (4.31, 5.42) mmol/L; P = 0.112] or zonulin [control, 1.36 (0.53, 2.15) ng/mL; FC, 0.94 (0.47, 1.56) ng/mL; P = 0.185] levels between FC patients and healthy controls.CONCLUSION: The intestinal mucosal barrier in FC patients exhibits a compensatory increase in goblet cells and integral intercellular junctions without activation of mucosal immunity or increased gut permeability.

Study on Colonic Transit Function, Gastrointestinal Hormones and Nitric Oxide Synthase in Different Types of Functional Constipation Patients

Clinical features and related factors of severe functional constipation

[Roles of Enteric Nervous System Neurotransmitters and Interstitial Cells of Cajal in the Colon in Slow Transit Constipation in Rats].

Psychological Characteristics and GoNogo Research of Patients with Functional Constipation.

The roles of nitric oxide in rats with slow-transit constipation and therapeutic efficacy of Traditional Chinese Medicine

Study on gastrointestinal motility in slow transit constipation

Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation

Roles of Gut Microbiota and Metabolites in Pathogenesis of Functional Constipation

A Clinical Study on Colonic Motility and Anorectal Manometry in Irritable Bowel Syndrome with Constipation and Functional Constipation

Characteristics of the Gut Microbiome and Serum Metabolome in Patients with Functional Constipation

Potential role of fecal microbiota in patients with constipation

Increased NOX1 and DUOX2 Expression in the Colonic Mucosa of Patients with Chronic Functional Constipation

Intestinal mucosal barrier in functional constipation: Dose it change?

Potential Role of Fecal Microbiota from Patients with Slow Transit Constipation in the Regulation of Gastrointestinal Motility

The gut microbiome and metabolites are altered and interrelated in patients with functional constipation

Pathogenesis of Disorders of the Motor Function of the Large Intestine in Functional Constipation

Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity

A Study on Colonic Transit Test and Ano-Manometry in Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome

Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation

Study on the characteristics of intestinal motility of constipation in patients with Parkinson's disease

The Changes of Gastrointestinal Hormones in Chronic Constipation